GoodRx
GDRX
3.25
-0.02
-0.61%
GoodRx
US · GDRX
#3178 by market cap
Listed 2020
3.25
-0.02
-0.61%
Live - 5344 symbols - heartbeat 300s ago
· 2026-10-08 08:13
Pre-market
3.20
-1.45%
After-hours
3.25
0.00%
- Market cap
- 1.11B
- P/E (TTM)i
- 54.17
- P/Bi
- 1.71
- EPSi
- 0.09
- Div yieldi
- 0.00%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on GDRX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- Total institutional ownership fell 2.3 percentage points.
Institutional ownership
- Held by institutions
- 45.48% -2.34pp
- Institutions
- 181
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
VC/PE Fund16.93%
Private Company13.53%
Mutual Fund10.59%
Individual/Insider3.94%
Hedge Fund3.54%
Public Company0.46%
Government Pension Fund0.35%
Other50.58%
Top holders as of 2026-08-21
Francisco Partners Management, L.P.
15.41% · 52.58M sh
Idea Men, LLC
12.65% · 43.16M sh
Douglas Hirsch
1.59% · 5.43M sh
Trevor Bezdek
1.59% · 5.43M sh
LSV Asset Management
1.51% · 5.16M sh
Columbia Management Investment Advisers, LLC
1.39% · 4.75M sh
Vanguard Capital Management, LLC
1.37% · 4.67M sh
Silver Lake Technology Management, L.L.C.
1.04% · 3.53M sh
Renaissance Technologies Corp.
0.95% · 3.25M sh
Vanguard Portfolio Management, LLC
0.94% · 3.21M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 16 sells
| Name | Role | Stake |
|---|---|---|
| Francisco Partners Management, L.P. | -- | 15.41% |
| Idea Men, LLC | -- | 12.65% |
| Douglas Hirsch | Co-founder, Chief Mission Officer & Director | 1.59% |
| Trevor Bezdek | Co-founder & Chairman | 1.59% |
| Wendy Barnes | Chief Executive Officer | 0.22% |
| Agnes Rey-Giraud | Independent Director | 0.17% |
| Raj Beri | Chief Operating Officer | 0.10% |
| Scott Wagner | Interim Chief Executive Officer | 0.08% |
| Christopher McGinnis | Chief Financial Officer | 0.06% |
| Romin Nabiey | Chief Accounting Officer & Principal Accounting Officer | 0.06% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-14 | Justin Fengler | Senior Vice President of Corporate Strategy & Business Operations | Derivative Exercise and Sale | -1,354 | $3.56 |
| 2026-09-14 | Justin Fengler | Senior Vice President of Corporate Strategy & Business Operations | Derivative Exercise and Retained | +1,733 | -- |
| 2026-09-14 | Thomas Chan | Chief Accounting Officer | Derivative Exercise and Sale | -1,069 | $3.56 |
| 2026-09-14 | Thomas Chan | Chief Accounting Officer | Derivative Exercise and Retained | +1,032 | -- |
| 2026-08-25 | Francisco Partners Management, L.P. | -- | Open Market Disposition | -1,567,044 | $3.44–3.51 |
| 2026-08-20 | Francisco Partners Management, L.P. | -- | Derivative Exercise and Sale | -5,932,956 | $3.50–3.53 |
| 2026-08-18 | Francisco Partners Management, L.P. | -- | Derivative Exercise and Retained | +1,567,044 | -- |
| 2026-08-14 | Justin Fengler | Senior Vice President of Corporate Strategy & Business Operations | Derivative Exercise and Sale | -21,407 | $3.73 |
| 2026-08-14 | Justin Fengler | Senior Vice President of Corporate Strategy & Business Operations | Derivative Exercise and Retained | +27,125 | -- |
| 2026-08-14 | Thomas Chan | Chief Accounting Officer | Derivative Exercise and Sale | -5,149 | $3.73 |
| 2026-08-14 | Thomas Chan | Chief Accounting Officer | Derivative Exercise and Retained | +4,966 | -- |
| 2026-08-09 | Justin Fengler | Senior Vice President of Corporate Strategy & Business Operations | Other Derivative Acquisition | +190,204 | -- |
| 2026-08-05 | Justin Fengler | Senior Vice President of Corporate Strategy & Business Operations | Initial Statement of Beneficial | 0 | -- |
| 2026-07-14 | Wendy Barnes | Chief Executive Officer | Derivative Exercise and Sale | -120,456 | $3.01 |
| 2026-07-14 | Wendy Barnes | Chief Executive Officer | Derivative Exercise and Retained | +156,832 | -- |
| 2026-07-14 | Christopher McGinnis | Chief Financial Officer | Derivative Exercise and Sale | -16,294 | $3.01 |
| 2026-07-14 | Christopher McGinnis | Chief Financial Officer | Derivative Exercise and Retained | +20,694 | -- |
| 2026-07-14 | Thomas Chan | Chief Accounting Officer | Derivative Exercise and Sale | -2,947 | $3.01 |
| 2026-07-14 | Thomas Chan | Chief Accounting Officer | Derivative Exercise and Retained | +2,845 | -- |
| 2026-06-15 | Agnes Rey-Giraud | Independent Director | Other Acquisition | +73,434 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:13:19 · For reference only, not investment advice and not tailored to your situation.